Home > Products > CD55 & HLA-A > Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (IgG(L)-scFv)

Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (IgG(L)-scFv)  (IGLFV-124)

Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD55 antibody are fused to the C terminus of an anti-HLA-A IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.

Specifications

Targets
CD55 & HLA-A
Type
Appended IgGs
Species Reactivity
Human
Target 1
CD55
Host Animal 1
Mouse
Target 2
HLA-A
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Renal cell cancer (RCC); Solid tumors

Targets

Target 1
CD55
Gene ID
UniProt ID
Alternative Names
CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CR; TC; DAF; CROM; complement decay-accelerating factor; CD55 antigen
Target 2
HLA-A
Gene ID
UniProt ID
Alternative Names
HLA-A; major histocompatibility complex, class I, A; HLAA; HLA class I histocompatibility antigen, A-1 alpha chain; antigen presenting molecule; leukocyte antigen class I-A; MHC class I antigen HLA-A heavy chain

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (IgG(L)-scFv) (IGLFV-124). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD55 & HLA-A"
See other bsAb targets related to "CD55"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: